Zarbock et al. (2021) conducted a multicenter randomized controlled trial demonstrating that urine [TIMP-2]·[IGFBP7], markers of cell cycle arrest, could predict moderate to severe AKI in cardiac surgery patients when used to guide a KDIGO care bundle [2]. Here, IGFBP7 is linked to acute kidney injury.